Donor-derived IP-10 initiates development of acute allograft rejection.
about
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' diseaseMechanisms of T cell organotropismAllograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profilingMicrofluidic mazes to characterize T-cell exploration patterns following activation in vitro.Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.Emerging therapies targeting intra-organ inflammation in transplantationStructure-function relationship between the human chemokine receptor CXCR3 and its ligandsHepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine ReleaseEmerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyIntravital microscopy identifies selectins that regulate T cell traffic into allografts.Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.Pin1 modulates the type 1 immune responseCXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model.CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectorsThe immunomodulatory role of syncytiotrophoblast microvesicles.The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1.A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.Protein-protein interaction network and mechanism analysis in ischemic strokeCXCR3 in T cell function.Endothelial injury: cause and effect of alloimmune inflammation.Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.The immunosuppressant Protosappanin A diminished recipient T cell migration into allograft via inhibition of IP-10 in rat heart transplant.CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.Tissue-intrinsic dysfunction of circadian clock confers transplant arteriosclerosis.Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Chemokine receptor-dependent alloresponses.Optimal modes and targets of gene therapy in transplantation.The chemokine system in innate immunity.Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma.Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group.Protective Effect of CXCR3⁺CD4⁺CD25⁺Foxp3⁺ Regulatory T Cells in Renal Ischemia-Reperfusion InjuryLong-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3.Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes.Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival.
P2860
Q24685509-625714BC-289E-41FF-9207-D8266819AAF3Q26753106-A9E6B0EB-57EF-48A4-8341-40B73776D8E6Q26996813-2E1B67D4-1030-4CAE-8325-B85B6BC9470CQ27334808-1DF024DE-EC56-4A3A-9F73-D92939EF9744Q27470828-F93B7E28-3E9E-4FFF-8F96-1934E08F7472Q28085496-4FDB0573-035D-4129-92D6-1D8386D3B8E3Q28213616-27B43281-FCAA-4D2B-888C-C35CC415AF79Q28263364-82E2C57C-8F79-41A7-B057-AABE50477567Q30438965-0292B491-C6AB-4EBB-8010-E1E3EA3D4193Q30492994-D751163F-AF14-47BC-B620-EE2F4757F30BQ33214938-FC646718-0B95-43A4-80DD-291BEDFADC85Q33274643-F36C8677-A56F-4F6F-8BA4-48F43F485E90Q33646444-164D088F-01DB-4C0F-B7C6-64CBA8ACAFFAQ33653089-BB232713-F6C3-4754-B8D1-EC719B951EF5Q33769652-248ABD42-B12B-4998-AD9C-3B299E3C222FQ33913346-B3ED627D-6F7C-4592-A0EB-774CAE4BB300Q33919724-B73BC5AF-F4FC-4B0E-8200-46FCCD94D670Q34079019-4427A1AD-4E1D-428D-A055-1868894E9669Q34122827-5A15C3C3-696E-41B6-8034-3B525DCCAE82Q34467148-2676DFDE-45E8-4338-B5E0-6194BAC3DC81Q34540909-EE08B058-E537-443D-B1C6-FA1187E8DAF1Q34726782-EB1D7714-28E2-4201-BA4A-7D5848B41CCAQ34991698-2B8BDDFB-946F-40A0-8062-35B8910B57E2Q35118386-481A42C5-4AB1-456D-8D06-5A8A62EA8EE5Q35163398-3E305CA4-81A0-49FD-86B1-A22FABE47AFCQ35223948-C83FDFF2-C0FF-436C-B282-AE6DB40203D8Q35345992-A4B787AA-F8BD-4F0B-90A9-A719DF541AB7Q35541507-DE18CB56-7D9E-44D6-9C10-754A31785D65Q35583497-F4B01603-B145-42E9-A661-E3EF31E000B5Q35583526-FFD2B2F8-BE40-435E-BC02-7CD3882A4DE1Q35663961-5226D0C5-17D5-4522-B785-1C77515482A3Q35679173-BA9FE55C-CFAF-46EE-A5C9-BEE0259D2250Q35749012-33675148-0A99-4A0B-8DF9-07A9FB2D361EQ35792171-A140B792-6B53-46D7-B5C5-BCE3E04D9B01Q35932418-3A5C252A-CAF1-420E-B35B-84F16CB91E76Q35987153-D1069CC5-6D56-4FA3-987C-88D5BBEA6332Q36057989-98D10032-82E5-4FE9-8D46-F7EF8A0F88CEQ36183387-F4B9EB98-8750-43E3-9237-4B1C0E171D7CQ36241951-79A81464-700C-4B60-89EA-99EA047116EEQ36370261-1190EF37-AC32-4225-A219-35EADFEB22FC
P2860
Donor-derived IP-10 initiates development of acute allograft rejection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Donor-derived IP-10 initiates development of acute allograft rejection.
@ast
Donor-derived IP-10 initiates development of acute allograft rejection.
@en
type
label
Donor-derived IP-10 initiates development of acute allograft rejection.
@ast
Donor-derived IP-10 initiates development of acute allograft rejection.
@en
prefLabel
Donor-derived IP-10 initiates development of acute allograft rejection.
@ast
Donor-derived IP-10 initiates development of acute allograft rejection.
@en
P2093
P2860
P356
P1476
Donor-derived IP-10 initiates development of acute allograft rejection.
@en
P2093
P2860
P304
P356
10.1084/JEM.193.8.975
P407
P577
2001-04-01T00:00:00Z